Microneedles for Transdermal Delivery and Diagnostic Applications

Dear Colleagues,

We are pleased to invite you to contribute to the upcoming Pharmaceutics Special Issue entitled “Microneedles for Transdermal Delivery and Diagnostic Applications”.

Microneedle technologies have rapidly evolved as promising platforms for minimally invasive transdermal delivery and biosensing. This Special Issue aims to highlight recent progress in microneedles’ potential in drug and vaccine delivery, diagnostics, and personalized medicine.

We welcome both original research articles and comprehensive reviews covering all aspects of microneedle technology. Topics of interest include, but are not limited to, the following:

• Sustained, active, or sequential drug delivery systems;
• Microneedle platforms for interstitial fluid sampling and real-time diagnostics;
• Additive manufacturing and advanced microfabrication of microneedle systems;
• Integration of microneedles with wearable or electronic platforms;
• Delivery of biologics, nucleic acids, or cell-based therapeutics;
• Microneedles for dermatologic or localized treatment applications;
• Mechanical performance, modeling, and insertion behavior of microneedles;
• Translational, manufacturing, and regulatory aspects of microneedle technologies.

We look forward to receiving your valuable contributions to this Special Issue and to showcasing the most recent advances in this rapidly expanding field.

Dr. Jillian L. Perry
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.